Bausch Health Companies Inc.

29.87+0.4000+1.36%Vol 287.06K1Y Perf 82.26%
Apr 23rd, 2021 10:42 DELAYED
BID29.84 ASK29.86
Open29.49 Previous Close29.47
Pre-Market- After-Market-
 - -%  - -
Target Price
35.67 
Analyst Rating
Moderate Buy 1.56
Potential %
19.34 
Finscreener Ranking
     40.98
Insiders Trans % 3/6/12 mo.
-/-100/66 
Value Ranking
     34.37
Insiders Value % 3/6/12 mo.
-/-100/96 
Growth Ranking
     34.62
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/97 
Income Ranking
 —    -
Market Cap10.62B 
Earnings Rating
Neutral
Price Range Ratio 52W %
75.28 
Earnings Date
4th May 2021

Today's Price Range

29.2929.93

52W Range

14.8634.80

5 Year PE Ratio Range

-14.804.20

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Week
-1.86%
1 Month
-6.92%
3 Months
10.54%
6 Months
60.51%
1 Year
82.26%
3 Years
68.02%
5 Years
-18.09%
10 Years
-

TickerPriceChg.Chg.%
BHC29.870.40001.36
AAPL133.541.60001.21
GOOG2 292.6424.72001.09
MSFT259.031.86000.72
XOM55.780.51000.92
WFC43.570.87002.04
JNJ165.520.34000.21
FB298.281.76000.59
GE13.580.17001.27
JPM149.562.19001.49
Financial StrengthValueIndustryS&P 500US Markets
0.40
1.10
0.98
44.72
0.40
Leverage Ratio 62.20
ProfitabilityValueIndustryS&P 500US Markets
71.60
7.50
30.20
-26.80
-6.74
RevenueValueIndustryS&P 500US Markets
5.90B
16.58
-2.49
-5.90
Earnings HistoryEstimateReportedSurprise %
Q04 20201.111.3319.82
Q03 20201.021.3128.43
Q02 20200.660.47-28.79
Q01 20200.900.89-1.11
Q04 20191.151.150.00
Q03 20191.061.1912.26
Q02 20191.061.03-2.83
Q01 20190.891.0315.73
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.95-5.94Negative
6/2021 QR1.01-3.81Negative
12/2021 FY4.370.46Positive
12/2022 FY4.91-1.41Negative
Next Report Date4th May 2021
Estimated EPS Next Report0.95
Estimates Count6
EPS Growth Next 5 Years %13.10
Volume Overview
Volume287.06K
Shares Outstanding355.62M
Trades Count2.19K
Dollar Volume224.94M
Avg. Volume4.57M
Avg. Weekly Volume1.76M
Avg. Monthly Volume2.01M
Avg. Quarterly Volume4.59M

Bausch Health Companies Inc. (NYSE: BHC) stock closed at 29.47 per share at the end of the most recent trading day (a -0.27% change compared to the prior day closing price) with a volume of 979.01K shares and market capitalization of 10.62B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 21600 people. Bausch Health Companies Inc. CEO is Joseph C. Papa.

The one-year performance of Bausch Health Companies Inc. stock is 82.26%, while year-to-date (YTD) performance is 41.68%. BHC stock has a five-year performance of -18.09%. Its 52-week range is between 14.86 and 34.8, which gives BHC stock a 52-week price range ratio of 75.28%

Bausch Health Companies Inc. currently has a PE ratio of -18.20, a price-to-book (PB) ratio of 19.95, a price-to-sale (PS) ratio of 1.76, a price to cashflow ratio of 9.60, a PEG ratio of 2.32, a ROA of -1.65%, a ROC of -1.79% and a ROE of -66.18%. The company’s profit margin is -6.74%, its EBITDA margin is 30.20%, and its revenue ttm is $5.90 Billion , which makes it $16.58 revenue per share.

Of the last four earnings reports from Bausch Health Companies Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.95 for the next earnings report. Bausch Health Companies Inc.’s next earnings report date is 04th May 2021.

The consensus rating of Wall Street analysts for Bausch Health Companies Inc. is Moderate Buy (1.56), with a target price of $35.67, which is +19.34% compared to the current price. The earnings rating for Bausch Health Companies Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bausch Health Companies Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bausch Health Companies Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 27.82, ATR14 : 1.07, CCI20 : -91.47, Chaikin Money Flow : -0.07, MACD : 0.02, Money Flow Index : 30.68, ROC : -5.67, RSI : 57.94, STOCH (14,3) : 37.53, STOCH RSI : 0.37, UO : 43.20, Williams %R : -62.47), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bausch Health Companies Inc. in the last 12-months were: Christina Ackermann (Option Excercise at a value of $0), John A. Paulson (Buy at a value of $166 503 072), Joseph C. Papa (Option Excercise at a value of $0), Joseph F. Gordon (Option Excercise at a value of $0), Paul S. Herendeen (Option Excercise at a value of $0), Sam Eldessouky (Option Excercise at a value of $0), Thomas Appio (Option Excercise at a value of $0), William D. Humphries (Option Excercise at a value of $2 169 352), William D. Humphries (Sold 156 526 shares of value $3 080 553 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
12 (75.00 %)
13 (76.47 %)
12 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (6.67 %)
Hold
3 (18.75 %)
3 (17.65 %)
1 (6.67 %)
Moderate Sell
1 (6.25 %)
1 (5.88 %)
1 (6.67 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.56
Strong Buy
1.53
Strong Buy
1.37

Bausch Health Companies Inc.

Bausch Health Companies Inc is a multinational, specialty pharmaceutical and medical device company that develops, manufactures and markets a broad range of branded generic pharmaceuticals, over-the-counter products and medical devices. The company operating business segments are Bausch+Lomb and international, Salix pharmaceuticals, ortho dermatology, and diversified products.

CEO: Joseph C. Papa

Telephone: +1 514 744-6792

Address: 2150 Saint Elzear Boulvard West, Laval H7L 4A8, QC, CA

Number of employees: 21 600

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

57%43%

Bearish Bullish

58%43%

Bearish Bullish

59%41%

News

Stocktwits